Some have relabeled it as Pentadecapeptide Aringate or PDA (transforming the acetate to an arginate) and they are prescribing it for subcutaneous administration this way, though the confusion about its position has led to a lively oral capsule market for BPC in what seems to generally be a grey region https://louisywtom.howeweb.com/38544307/getting-my-primoteston-depot-250-mg-sydney-shogun-bpc-157-5mg-to-work